First Time Loading...

Stereotaxis Inc
NYSE-MKT:STXS

Watchlist Manager
Stereotaxis Inc Logo
Stereotaxis Inc
NYSE-MKT:STXS
Watchlist
Price: 1.92 USD Market Closed
Updated: Jun 6, 2024

Stereotaxis Inc
Operating Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Stereotaxis Inc
Operating Income Peer Comparison

Comparables:
BDX
BSX
SYK
ABT
ISRG

Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
Stereotaxis Inc
NYSE-MKT:STXS
Operating Income
-$21m
CAGR 3-Years
-50%
CAGR 5-Years
-43%
CAGR 10-Years
-11%
Becton Dickinson and Co
NYSE:BDX
Operating Income
$2.2B
CAGR 3-Years
9%
CAGR 5-Years
-3%
CAGR 10-Years
6%
Boston Scientific Corp
NYSE:BSX
Operating Income
$2.5B
CAGR 3-Years
47%
CAGR 5-Years
7%
CAGR 10-Years
11%
Stryker Corp
NYSE:SYK
Operating Income
$4.5B
CAGR 3-Years
17%
CAGR 5-Years
7%
CAGR 10-Years
7%
Abbott Laboratories
NYSE:ABT
Operating Income
$6.6B
CAGR 3-Years
-1%
CAGR 5-Years
11%
CAGR 10-Years
13%
Intuitive Surgical Inc
NASDAQ:ISRG
Operating Income
$1.9B
CAGR 3-Years
16%
CAGR 5-Years
9%
CAGR 10-Years
11%

See Also

What is Stereotaxis Inc's Operating Income?
Operating Income
-21m USD

Based on the financial report for Mar 31, 2024, Stereotaxis Inc's Operating Income amounts to -21m USD.

What is Stereotaxis Inc's Operating Income growth rate?
Operating Income CAGR 10Y
-11%

Over the last year, the Operating Income growth was -3%. The average annual Operating Income growth rates for Stereotaxis Inc have been -50% over the past three years , -43% over the past five years , and -11% over the past ten years .